This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Valo Therapeutics Oy. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Tuuli Ranki - Innovator in Cancer Therapy
Introduction
Tuuli Ranki is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of cancer therapy through his innovative work. His research focuses on utilizing modified oncolytic adenoviruses to develop effective treatments for cancer.
Latest Patents
Tuuli Ranki holds a patent related to cancer therapy. The invention concerns a modified oncolytic adenovirus, a pharmaceutical composition comprising the same, and a method of treating cancer using this technology. This patent represents a significant advancement in the fight against cancer, showcasing Ranki's commitment to improving patient outcomes.
Career Highlights
Tuuli Ranki is associated with Valo Therapeutics Oy, a company dedicated to developing novel cancer therapies. His work at Valo Therapeutics has positioned him as a key player in the biotechnology sector, where he continues to push the boundaries of cancer treatment.
Collaborations
Tuuli Ranki collaborates with talented professionals in his field, including Sari Pesonen and Petri Priha. These collaborations enhance the research and development efforts at Valo Therapeutics, fostering innovation and progress in cancer therapy.
Conclusion
Tuuli Ranki's contributions to cancer therapy through his patented invention and work at Valo Therapeutics Oy highlight his dedication to advancing medical science. His innovative approach has the potential to make a significant impact on cancer treatment and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile